Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 69.00
-0.80 (-1.15%)
At close: Mar 26, 2026
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 10.86 billion as of March 26, 2026. Its market cap has decreased by -16.34% in one year.
Market Cap
10.86B
Enterprise Value
8.29B
Revenue
1.62B
Ranking
n/a
PE Ratio
15.22
Stock Price
69.00
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 10.86B, an increase of 30.49%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 10.98B | -18.84% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 19.82B |
| Grape King Bio | 17.78B |
| ScinoPharm Taiwan | 16.45B |
| Synmosa Biopharma | 15.45B |
| YungShin Global Holding | 14.04B |
| Foresee Pharmaceuticals | 12.18B |
| Alar Pharmaceuticals | 11.39B |
| Standard Chemical & Pharmaceutical | 11.22B |